In a filing, CVS Health Corp revealed its SVP, Cont & Chief Acct Officer Clark James David unloaded Company’s shares for reported $0.5 million on Mar 05 ’25. In the deal valued at $66.35 per share,7,513 shares were sold. As a result of this transaction, Clark James David now holds 8,394 shares worth roughly $0.56 million.
Then, Clark James David bought 7,513 shares, generating $498,489 in total proceeds.
Before that, Mahoney Michael F bought 30,000 shares. CVS Health Corp shares valued at $2,001,000 were divested by the Director at a price of $66.70 per share. As a result of the transaction, Mahoney Michael F now holds 39,356 shares, worth roughly $2.61 million.
Leerink Partners upgraded its CVS Health Corp [CVS] rating to an Outperform from a a Market perform in a research note published on February 13, 2025; the price target was increased to $75 from $55. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who increased its forecast for the stock in mid February from “a Neutral” to “an Overweight”. Edward Jones also remained covering CVS and has increased its forecast on January 30, 2025 with a “Buy” recommendation from previously “Hold” rating. Deutsche Bank revised its rating on December 03, 2024. It rated CVS as “a Buy” which previously was an “a Hold”.
Price Performance Review of CVS
On Friday, CVS Health Corp [NYSE:CVS] saw its stock jump 1.66% to $66.33. Over the last five days, the stock has gained 0.93%. CVS Health Corp shares have risen nearly 47.76% since the year began. Nevertheless, the stocks have fallen -10.01% over the past one year. While a 52-week high of $80.75 was reached on 02/13/25, a 52-week low of $43.56 was recorded on 01/02/25. SMA at 50 days reached $55.78, while 200 days put it at $57.52.
Levels Of Support And Resistance For CVS Stock
The 24-hour chart illustrates a support level at 64.52, which if violated will result in even more drops to 62.72. On the upside, there is a resistance level at 67.61. A further resistance level may holdings at 68.90. The Relative Strength Index (RSI) on the 14-day chart is 66.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 16.32%. Stochastics %K at 73.42% indicates the stock is a holding.
